On a grey September morning in 2024, the founders, Sam and Nok, opened the doors of CORE Soft Tissue Therapy in Dulwich with ...

The donated systems are an investigational medical device in the United States and have not been approved or cleared by the U.S. Food and Drug Administration (FDA) for sale or distribution. NIRSense ...

HANGZHOU, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- In today’s rapidly evolving healthcare ...

This review innovatively proposes the use of electrospinning to fabricate electroactive fibrous scaffolds, which mimic the structure of the extracellular matrix while providing electrical activity, ...

Scientists at the Paul Scherrer Institute PSI have refined an X-ray diffraction technique for detecting biological structures ...

Patients with hospital-acquired Stage IV bedsores require acute hospitalization and early surgical debridement, clinitron beds, medical optimization, wound preparation, and reconstructive surgery.” — ...

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

Today, NIRSense and Aspen Medical USA (AMUSA) are pleased to announce the donation of 12 portable tissue-ischemia monitoring kits (comprising advanced sensor consoles plus tablets) to the Ministry of ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As sleep disorders such as obstructive sleep apnea ...

Mobile, tackles one of the biggest questions at CES: what does a strong media strategy look like in the age of AI? With T-Mobile reporting $81.4 billion in revenue and serving 140 million subscribers, ...

Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...